The Russian Direct Investment Fund (RDIF) and Dr. Reddy's laboratory has received renewed approval to conduct late-stage clinical trials in India.
This new trial will have 1500 participants. Dr. Reddy's will do the clinical trials, and if approved will distribute the vaccine. RDIF will supply 100 million doses to Reddy's.
Other countries where sputnik V will be tried are Belarus, Venezuela and UAE. Russia is doing a Phase III trial with 40,000 participants.
If everything goes well Indian manufacturer will produce 300 million doses.
The above is abstracted from the Reuters' site.
https://www.reuters.com/article/health-coronavirus-russia-india-idUSR4N2GK04T
Links to Sputnik V
No comments:
Post a Comment